Bank of New York Mellon’s BioNTech BNTX Stock Holding History

Bank of New York Mellon’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Sell	28,685 -11,798	-29%	-$1.11M	﹤0.01%	2782
2026 Q1	$3.6M	Sell	40,483 -73,978	-65%	-$7.6M	﹤0.01%	2499
2025 Q4	$10.9M	Sell	114,461 -454,246	-80%	-$45.8M	﹤0.01%	1877
2025 Q3	$56.1M	Sell	568,707 -540,012	-49%	-$57.7M	0.01%	942
2025 Q2	$118M	Buy	1,108,719 +410,351	+59%	+$41.4M	0.02%	561
2025 Q1	$63.6M	Buy	698,368 +694,691	+18,893%	+$77.8M	0.01%	814
2024 Q4	$419K	Buy	3,677 +150	+4%	+$17.1K	﹤0.01%	3616
2024 Q3	$419K	Sell	3,527 -377	-10%	-$34.7K	﹤0.01%	3607
2024 Q2	$314K	Sell	3,904 -83	-2%	-$7.59K	﹤0.01%	3795
2024 Q1	$368K	Buy	3,987 +176	+5%	+$16.9K	﹤0.01%	3696
2023 Q4	$402K	Buy	+3,811	New	+$384K	﹤0.01%	3672
2022 Q1	–	Sell	-4,359	Closed	-$1.12M	–	4665
2021 Q4	$1.12M	Buy	4,359 +1,601	+58%	+$438K	﹤0.01%	3319
2021 Q3	$753K	Sell	2,758 -27,762	-91%	-$8.82M	﹤0.01%	3566
2021 Q2	$6.83M	Buy	30,520 +10,920	+56%	+$2.06M	﹤0.01%	2342
2021 Q1	$2.14M	Buy	+19,600	New	+$2.08M	﹤0.01%	2889

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Bank of New York Mellon's BNTX Position: Q2 2026 in Review

Bank of New York Mellon reduced its BioNTech (BNTX) stake by 29% in Q2 2026, selling an estimated $1.11M and leaving 28,685 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2782.

Bank of New York Mellon first reported a position in BNTX in Q1 2021 and has held it in 15 quarters since. The position peaked at $118M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Bank of New York Mellon held 28,685 shares of BioNTech worth $2.67M as of Q2 2026.
Bank of New York Mellon sold 11,798 BioNTech shares in Q2 2026, an estimated $1.11M.
BioNTech made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2782 holding.
Bank of New York Mellon first reported a position in BioNTech in Q1 2021 and has held it in 15 quarters since.
Bank of New York Mellon's BioNTech position peaked at $118M in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.